We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Carriage Rates in Resident Physicians

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00929435
Recruitment Status : Terminated (Minimal enrollment)
First Posted : June 29, 2009
Last Update Posted : April 9, 2012
Information provided by (Responsible Party):
Gary Kinasewitz, University of Oklahoma

Brief Summary:
One hundred new residents will be recruited prior to the start of residency and followed prospectively for a year. Monthly nasal swabs will be performed to identify colonization with methicillin resistant staphylococcus aureus (MRSA).The proportion of study subjects colonized with MRSA at the end of 1 year will be calculated.

Condition or disease
MRSA Colonization

Detailed Description:

This is a prospective observational study looking at the incidence of MRSA colonization. New residents will be monitored every month with nasal swabs.We would like to elucidate factors responsible for MRSA colonization in healthcare workers.We would like to see if health care workers who are colonized spontaneously cleared MRSA and if there was any factors involved.

Nasal swabs will be plated on the spot by trained individuals and the plates then incubated for 48 hours. Plates will be read by microbiologist after incubation.

Study Type : Observational
Actual Enrollment : 30 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Nasal Carriage Among Resident Physicians
Study Start Date : June 2009
Primary Completion Date : January 2012
Study Completion Date : January 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: MRSA
U.S. FDA Resources

MRSA surveillance
Newly recruited resident physicians will be monitored for a year with nasal swabs monthly.

Primary Outcome Measures :
  1. To detect an increase in MRSA nasal carriage rate among newly appointed residents after 1 year of regular patient contact. [ Time Frame: 1 year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   25 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
All newly recruited residents will be eligible for enrollment.

Inclusion Criteria:

  • Study subjects will be newly appointed residents at the OU medical center

Exclusion Criteria:

  • Previous MRSA infection
  • Current use of mupirocin

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00929435

United States, Oklahoma
Oklahoma University health science center
Oklahoma City, Oklahoma, United States, 73104
Sponsors and Collaborators
University of Oklahoma
Principal Investigator: Gary T Kinasewitz, MD University of Oklahoma

Responsible Party: Gary Kinasewitz, Principal Investigator, University of Oklahoma
ClinicalTrials.gov Identifier: NCT00929435     History of Changes
Other Study ID Numbers: 14684
First Posted: June 29, 2009    Key Record Dates
Last Update Posted: April 9, 2012
Last Verified: April 2012

Keywords provided by Gary Kinasewitz, University of Oklahoma:
Contact isolation

Additional relevant MeSH terms:
Staphylococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Anti-Bacterial Agents
Anti-Infective Agents